CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
68.89
-0.92 (-1.32%)
Apr 8, 2026, 2:43 PM EDT - Market open
CG Oncology Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$73.09
Upside
+6.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $100 | Strong Buy | Maintains | $80 → $100 | +45.16% | Apr 7, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $80 | Strong Buy | Maintains | $75 → $80 | +16.13% | Feb 27, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $66 → $75 | Strong Buy | Maintains | $66 → $75 | +8.87% | Feb 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $61 → $73 | Buy | Maintains | $61 → $73 | +5.97% | Jan 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $55 → $70 | Buy | Maintains | $55 → $70 | +1.61% | Jan 16, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $62 → $66 | Strong Buy | Maintains | $62 → $66 | -4.20% | Jan 12, 2026 |
| Wedbush | Wedbush | Buy Initiates $70 | Buy | Initiates | $70 | +1.61% | Dec 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | -10.00% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $61 | Buy | Maintains | $53 → $61 | -11.45% | Nov 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +30.64% | Oct 8, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $41 → $47 | Buy | Maintains | $41 → $47 | -31.78% | Sep 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $79 | Buy | Maintains | $56 → $79 | +14.68% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +8.87% | Sep 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | -27.42% | Sep 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +8.87% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +8.87% | Sep 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.